查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
体外诊断品管的全球市场 - 策略与趋势，各化验类型，场所，各产品类型，各製造厂商，各国预测 - 附执行顾问指南(2024年～2028年)
市场调查报告书
商品编码
1507969

体外诊断品管的全球市场 - 策略与趋势，各化验类型，场所，各产品类型，各製造厂商，各国预测 - 附执行顾问指南(2024年～2028年)

In Vitro Diagnostic Quality Control Market. Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country. Situation Analysis with Executive & Consultant Guides. 2024 to 2028
出版日期: | 出版商: Howe Sound Research | 英文 367 Pages | 商品交期: 最快1-2个工作天内

价格

体外诊断品质控制产业正面临疫情的课题。这个行业没有经历衰退，现在充满了新的机会。

临床测试将直接受益于生物技术（尤其是基因组学）的爆炸性发展。各种动态趋势正在推动市场成长和公司估值。品质控制行业将从中受益。

本报告提供全球体外诊断品管市场相关调查，提供市场概要，以及各化验类型，场所，各产品类型，各製造厂商，各国趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 市场指南

第2章 简介和市场定义

  • 体外诊断品管是什么吗
  • 机会定义
  • 调查手法
  • 观点:医疗保健和IVD产业

第3章 动态的市场概要

  • 市场进入组织
    • 学术研究机关
    • 诊断测试开发商
    • 仪器供应商
    • 药品·试剂厂商
    • 病理供应商
    • 独立型临床检验室
    • 公共的国立/地区研究所
    • 医院检验室
    • 临床检验室
    • 审核机关
    • 认证机关
  • 市场区隔- 各种方法
  • 临床检验产业结构
  • 国家与地区的多样性

第4章 不断变化的市场推动趋势

  • 成长由多方面推动
  • 市场萎缩的因素
  • 自动化与实验室趋势

第5章 体外诊断品管的最近的趋势

第6章 主要企业的简介

  • Abbott Laboratories
  • Alpha-Tec Systems
  • Beckman Coulter Diagnostics(Danaher)
  • Becton, Dickinson and Company
  • BioFire Diagnostics(bioMerieux)
  • bioMerieux Diagnostics
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • Danaher Corporation
  • Diasorin S.p.A.
  • Fortress Diagnostics
  • Grifols
  • Helena Laboratories
  • Hologic
  • LGC Standards
  • Maine Molecular Quality Controls
  • Microbiologics
  • Microbix Systems
  • Novacyt
  • QuidelOrtho
  • Randox Toxicology
  • Seegene
  • SERO
  • Siemens Healthineers
  • Streck
  • Sun Diagnostics
  • Sysmex
  • Thermo Fisher Scientific
  • ZeptoMetrix

第7章 体外诊断品管的全球市场

  • 各国全球市场概要
  • 各化验类型全球市场概要
  • 各地区全球市场概要
  • 各产品全球市场概要
  • 各製造厂商全球市场- 概要

第8章 全球体外诊断品管市场- 各化验类型

  • 化学
  • 微生物学
  • 血液学
  • 解剖病理学
  • 分子诊断
  • 费解

第9章 全球体外诊断品管市场- 场所

  • 医院
  • 门诊病人检验室
  • 研究室
  • 诊疗所检验室
  • 其他的研究室

第10章 全球体外诊断品管市场- 各产品

  • 全血
  • 血浆
  • 尿
  • 其他

第11章 全球体外诊断品管市场- 各製造厂商

  • 原始设备厂商
  • 第三方的非专利
  • 第三方的设备
  • 自订及其他

第12章 附录

OVERVIEW:

The IVD Quality Control industry rose to the challenge of the pandemic. Now new opportunities abound in this established industry that is immune from recession. New technology and new segments are driving runaway growth. Understand the opportunities and the threats in this comprehensive report.

The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations. The Quality Control industry stands to gain.

The report provides data that analysts and planners can use. Hundreds of pages of information including detailed information on clinical laboratory trends and the role of IVD. Forecast demand for new testing regimes or technologies.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1 Market Guides

  • 1.1 Strategic Situation Analysis
  • 1.2 Guide for Executives, Marketing, Sales and Business Development Staff
  • 1.3 Guide for Management Consultants and Investment Advisors

2 Introduction and Market Definition

  • 2.1 What is IVD Quality Control?
  • 2.2 Defining the Opportunity
    • 2.2.1 Revenue Market Size
  • 2.3 Methodology
    • 2.3.1 Methodology
    • 2.3.2 Sources
    • 2.3.3 Authors
  • 2.4 Perspective: Healthcare and the IVD Industry
    • 2.4.1 Global Healthcare Spending
    • 2.4.2 Spending on Diagnostics
    • 2.4.3 Important Role of Insurance for Diagnostics

3 Overview of a Dynamic Market

  • 3.1 Players in a Dynamic Market
    • 3.1.1 Academic Research Lab
    • 3.1.2 Diagnostic Test Developer
    • 3.1.3 Instrumentation Supplier
    • 3.1.4 Chemical/Reagent Supplier
    • 3.1.5 Pathology Supplier
    • 3.1.6 Independent Clinical Laboratory
    • 3.1.7 Public National/regional Laboratory
    • 3.1.8 Hospital Laboratory
    • 3.1.9 Physicians Office Lab (POLS)
    • 3.1.10 Audit Body
    • 3.1.11 Certification Body
  • 3.2 Segmentation - Different Approaches
    • 3.2.1 Traditional Market Segmentation
    • 3.2.2 Laboratory Focus and Segmentation
  • 3.3 Structure of Clinical Testing Industry
    • 3.3.1 The Hospital Lab - Share of the Pie
    • 3.3.2 Key Role for Economies of Scale
    • 3.3.3 Physician Office Lab's are Still Here
    • 3.3.4 Physician's and POCT - Reviving Patient Service in China
  • 3.4 National and Regional Diversity

4 Trends Driving a Changing Market

  • 4.1 Growth Is Pushed from Many Sides
    • 4.1.1 Demographic Impacts on Consumption
    • 4.1.2 Alternative Suppliers
    • 4.1.3 Impact of POC
    • 4.1.4 Impact of Accreditation
    • 4.1.5 Genetic and Molecular Issues
  • 4.2 Factors at Work to Shrink the Market
    • 4.2.1 Where are Costs Going?
    • 4.2.2 Management Practices
    • 4.2.3 Cannabilization
    • 4.2.4 Point of Care
  • 4.3 Automation and Laboratory Trends
    • 4.3.1 Traditional Automation and Centralization
    • 4.3.2 The New Automation, Decentralization and Point Of Care
    • 4.3.3 Instruments Key to Market Share
    • 4.3.4 Bioinformatics Plays a Role
    • 4.3.5 PCR Takes Command
    • 4.3.6 Next Generation Sequencing Fuels a Revolution
    • 4.3.7 NGS Impact on Pricing
    • 4.3.8 Whole Genome Sequencing, A Brave New World
    • 4.3.9 Companion Diagnostics Blurs Diagnosis and Treatment
    • 4.3.10 Shifting Role of Diagnostics

5 IVD Quality Control Recent Developments

  • 5.1 Recent Developments - Importance and How to Use This Section
    • 5.1.1 Importance of These Developments
    • 5.1.2 How to Use This Section
  • 5.2 New FDA Quality Regulations Spark Questions
  • 5.3 Waters MassTrak Steroid Serum (IVD) Sets
  • 5.4 Cancer Test Harmonization Efforts Progress
  • 5.5 Bio-Techne Expanding With Ella Immunoassay Instrument
  • 5.6 ZeptoMetrix QC Products Receive IVDR Certification
  • 5.7 Coverage Criteria for Cancer Genetic Tests Creates Alarm
  • 5.8 IVDR Rollout Brings QC Hurdles for Clinical Labs
  • 5.9 LGC Clinical Diagnostics Acquires QC Product Maker Kova International
  • 5.10 FDA Probing Lab Test Quality in Cancer Care
  • 5.11 Sensible Diagnostics to Launch 10-Minute POC PCR System
  • 5.12 Streck Gets FDA Clearance for BioFire Sepsis Panel Control Material

6 Profiles of Key Companies

  • 6.1 Abbott Laboratories
  • 6.2 Alpha-Tec Systems
  • 6.3 Beckman Coulter Diagnostics (Danaher)
  • 6.4 Becton, Dickinson and Company
  • 6.5 BioFire Diagnostics (bioMerieux)
  • 6.6 bioMerieux Diagnostics
  • 6.7 Bio-Rad Laboratories, Inc
  • 6.8 Bio-Techne
  • 6.9 Danaher Corporation
  • 6.10 Diasorin S.p.A.
  • 6.11 Fortress Diagnostics
  • 6.12 Grifols
  • 6.13 Helena Laboratories
  • 6.14 Hologic
  • 6.15 LGC Standards
  • 6.16 Maine Molecular Quality Controls
  • 6.17 Microbiologics
  • 6.18 Microbix Systems
  • 6.19 Novacyt
  • 6.20 QuidelOrtho
  • 6.21 Randox Toxicology
  • 6.22 Seegene
  • 6.23 SERO
  • 6.24 Siemens Healthineers
  • 6.25 Streck
  • 6.26 Sun Diagnostics
  • 6.27 Sysmex
  • 6.28 Thermo Fisher Scientific
  • 6.29 ZeptoMetrix

7 The Global Market for IVD Quality Control

  • 7.1 Global Market Overview by Country
    • 7.1.1 Table - Global Market by Country
    • 7.1.2 Chart-Global Market by Country
  • 7.2 Global Market by Assay Type-Overview
    • 7.2.1 Table - Global Market by Assay Type
    • 7.2.2 Chart - Global Market by Assay Type - Base/Final Year Comparison
    • 7.2.3 Chart - Global Market by Assay Type - Base Year
    • 7.2.4 Chart - Global Market by Assay Type - End Year
    • 7.2.5 Chart - Global Market by Assay Type - Share by Year
    • 7.2.6 Chart - Global Market by Assay Type - Segments Growth
  • 7.3 Global Market by Place-Overview
    • 7.3.1 Table - Global Market by Place
    • 7.3.2 Chart - Global Market by Place - Base/Final Year Comparison
    • 7.3.3 Chart - Global Market by Place - Base Year
    • 7.3.4 Chart - Global Market by Place - End Year
    • 7.3.5 Chart - Global Market by Place - Share by Year
    • 7.3.6 Chart - Global Market by Place - Segments Growth
  • 7.4 Global Market by Product-Overview
    • 7.4.1 Table - Global Market by Product
    • 7.4.2 Chart - Global Market by Product - Base/Final Year Comparison
    • 7.4.3 Chart - Global Market by Product - Base Year
    • 7.4.4 Chart - Global Market by Product - End Year
    • 7.4.5 Chart - Global Market by Product - Share by Year
    • 7.4.6 Chart - Global Market by Product - Segments Growth
  • 7.5 Global Market by Manufacturer- Overview
    • 7.5.1 Table - Global Market by Manufacturer
    • 7.5.2 Chart - Global Market by Manufacturer - Base/Final Year Comparison
    • 7.5.3 Chart - Global Market by Manufacturer - Base Year
    • 7.5.4 Chart - Global Market by Manufacturer - End Year
    • 7.5.5 Chart - Global Market by Manufacturer - Share by Year
    • 7.5.6 Chart - Global Market by Manufacturer - Segments Growth

8 Global IVD Quality Control Markets - By Assay Type

  • 8.1 Chemistry
    • 8.1.1 Table Chemistry - by Country
    • 8.1.2 Chart-Chemistry Growth
  • 8.2 Microbiology
    • 8.2.1 Table Microbiology - by Country
    • 8.2.2 Chart-Microbiology Growth
  • 8.3 Hematology
    • 8.3.1 Table Hematology - by Country
    • 8.3.2 Chart-Hematology Growth
  • 8.4 Anatomic Pathology
    • 8.4.1 Table Anatomic Pathology - by Country
    • 8.4.2 Chart-Anatomic Pathology Growth
  • 8.5 Molecular Diagnostics
    • 8.5.1 Table Molecular Diagnostics - by Country
    • 8.5.2 Chart-Molecular Diagnostics Growth
  • 8.6 Esoteric
    • 8.6.1 Table Esoteric - by Country
    • 8.6.2 Chart-Esoteric Growth

9 Global IVD Quality Control Markets - By Place

  • 9.1 Hospital
    • 9.1.1 Table Hospital - by Country
    • 9.1.2 Chart-Hospital Growth
  • 9.2 Outpatient Laboratory
    • 9.2.1 Table Outpatient Laboratory - by Country
    • 9.2.2 Chart - Outpatient Laboratory Growth
  • 9.3 Research Laboratory
    • 9.3.1 Table Research Laboratory - by Country
    • 9.3.2 Chart-Research Laboratory Growth
  • 9.4 Physicians Office Laboratory
    • 9.4.1 Table Physicians Office Laboratory - by Country
    • 9.4.2 Chart-Physicians Office Laboratory Growth
  • 9.5 Other Laboratory
    • 9.5.1 Table Other Laboratory - by Country
    • 9.5.2 Chart-Other Laboratory Growth

10 Global IVD Quality Control Markets - By Product

  • 10.1 Whole Blood
    • 10.1.1 Table Whole Blood- by Country
    • 10.1.2 Chart - Whole Blood Growth
  • 10.2 Plasma
    • 10.2.1 Table Plasma - by Country
    • 10.2.2 Chart - Plasma Growth
  • 10.3 Urine
    • 10.3.1 Table Urine - by Country
    • 10.3.2 Chart -Urine Growth
  • 10.4 Control Material Other
    • 10.4.1 Table Control Material Other - by Country
    • 10.4.2 Chart-Control Material Other Growth

11 Global IVD Quality Control Markets - By Manufacturer

  • 11.1 Original Equipment Manufacturer
    • 11.1.1 Table Original Equipment Manufacturer - by Country
    • 11.1.2 Chart - Original Equipment Manufacturer Growth
  • 11.2 Third Party Generic
    • 11.2.1 Table Third Party Generic - by Country
    • 11.2.2 Chart - Third Party Generic Growth
  • 11.3 Third Party Instrument Specific
    • 11.3.1 Table Third Party Instrument Specific - by Country
    • 11.3.2 Chart - Third Party Instrument Specific Growth
  • 11.4 Custom Other
    • 11.4.1 Table Custom Other - by Country
    • 11.4.2 Chart - Custom Other Growth

12 Appendices

  • 12.1 Growth of Approved IVD Test Menu
  • 12.2 Growth of Approved Average IVD Test Fee
  • 12.3 The Most Used IVD Assays
  • 12.4 The Highest Grossing Assays
  • 12.5 Laboratory Fees Schedule

Table of Tables

  • Table 1 Market Players by Type
  • Table 2 Clinical Laboratory Departments and Segments
  • Table 3 Laboratory Management Focus - Different Approaches
  • Table 4 Key Segmentation Variables Going Forward
  • Table 5 Factors Affecting Local Clinical Testing Demand
  • Table 6 Seven Factors Driving Growth
  • Table 7 Six Factors Limiting Growth
  • Table 8 Seven Key Diagnostic Laboratory Technology Trends
  • Table 9-Global Market by Region
  • Table 10 Global Market by Assay Type
  • Table 11 Global Market by Place
  • Table 12 Global Market by Product
  • Table 13 Global Market by Manufacturer
  • Table 14 Chemistry by Country
  • Table 15 Microbiology by Country
  • Table 16 Hematology by Country
  • Table 17 Anatomic Pathology by Country
  • Table 18 Molecular Diagnostics by Country
  • Table 19 Esoteric by Country
  • Table 20 Hospital by Country
  • Table 21 Outpatient Laboratory by Country
  • Table 22 Research Laboratory by Country
  • Table 23 Physicians Office Laboratory by Country
  • Table 24 Other Laboratory by Country
  • Table 25 Whole Blood by Country
  • Table 26 Plasma by Country
  • Table 27 Urine by Country
  • Table 28 Control Material Other by Country
  • Table 29 Original Equipment Manufacturer by Country
  • Table 30 Third Party Generic by Country
  • Table 31 Third Party Instrument Specific by Country
  • Table 32 Custom Other by Country
  • Table 33 The Most Common Assays
  • Table 34 Largest Revenue Assays
  • Table 35 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1 Global Healthcare Spending
  • Figure 2 The Road to Diagnostics
  • Figure 3 The Changing Age of The World's Population
  • Figure 4 Health Care Consumption by Age
  • Figure 5 Cancer Incidence - Age at Diagnosis
  • Figure 6 Centralized vs. Decentralized Laboratory Service
  • Figure 7 A Highly Multiplexed Syndromic Testing Unit
  • Figure 8 The Real Cost to Sequence the Human Genome
  • Figure 9 The Codevelopment Process
  • Figure 10 Comparing MDx Diagnostic and Traditional Testing
  • Figure 11 Global Market Pareto Chart
  • Figure 12 Global Market by Assay Type-Base vs. Final
  • Figure 13 Global Market by Assay Type Base Year
  • Figure 14 Global Market by Assay Type End Year
  • Figure 15 Assay Type Share by Year
  • Figure 16 Assay Type Segments Growth
  • Figure 17 Global Market by Place-Base vs. Final
  • Figure 18 Global Market by Place Base Year
  • Figure 19 Global Market by Place End Year
  • Figure 20 Place Share by Year
  • Figure 21 Place Segments Growth
  • Figure 22 Global Market by Product-Base vs. Final
  • Figure 23 Global Market by Product Base Year
  • Figure 24 Global Market by Product End Year
  • Figure 25 Product Share by Year
  • Figure 26 Product Segments Growth
  • Figure 27 Global Market by Manufacturer-Base vs. Final
  • Figure 28 Global Market by Manufacturer Base Year
  • Figure 29 Global Market by Manufacturer End Year
  • Figure 30 Manufacturer Share by Year
  • Figure 31 Manufacturer Segments Growth
  • Figure 32 Chemistry Growth
  • Figure 33 Microbiology Growth
  • Figure 34 Hematology Growth
  • Figure 35 Anatomic Pathology Growth
  • Figure 36 Molecular Diagnostics Growth
  • Figure 37 Esoteric Growth
  • Figure 38 Hospital Growth
  • Figure 39 Out Patient Laboratory Growth
  • Figure 40 Research Laboratory Growth
  • Figure 41 Physicians Office Laboratory Growth
  • Figure 42 Other Laboratory Growth
  • Figure 43 Whole Blood Growth
  • Figure 44 Plasma Growth
  • Figure 45 Urine Growth
  • Figure 46 Control Material Other Growth
  • Figure 47 Original Equipment Manufacturer Growth
  • Figure 48 Third Party Generic Growth
  • Figure 49 Third Party Instrument Specific Growth
  • Figure 50 Custom Other Growth
  • Figure 51 IVD Test Menu Growth
  • Figure 52 IVD Test Average Fees - A Ten Year View